Connection

Yuko Palesch to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Yuko Palesch has written about Treatment Outcome.
Yuko Palesch
Connection Strength
1.361
Treatment Outcome
  1. Power and sample size simulations for Randomized Play-the-Winner rules. Contemp Clin Trials. 2007 Jul; 28(4):487-99.
    View in: PubMed
    Score: 0.126
  2. Statistical analysis plan for pooled individual patient data from two landmark randomized trials (INTERACT2 and ATACH-II) of intensive blood pressure lowering treatment in acute intracerebral hemorrhage. Int J Stroke. 2019 04; 14(3):321-328.
    View in: PubMed
    Score: 0.071
  3. Treatment effect on ordinal functional outcome using piecewise multistate Markov model with unobservable baseline: an application to the modified Rankin scale. J Biopharm Stat. 2019; 29(1):82-97.
    View in: PubMed
    Score: 0.070
  4. Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial. Stroke. 2015 May; 46(5):1321-7.
    View in: PubMed
    Score: 0.056
  5. A surrogate-primary replacement algorithm for response-adaptive randomization in stroke clinical trials. Stat Methods Med Res. 2017 Jun; 26(3):1078-1092.
    View in: PubMed
    Score: 0.055
  6. Regression analysis of ordinal stroke clinical trial outcomes: an application to the NINDS t-PA trial. Int J Stroke. 2014 Feb; 9(2):226-31.
    View in: PubMed
    Score: 0.049
  7. Covariate imbalance and adjustment for logistic regression analysis of clinical trial data. J Biopharm Stat. 2013; 23(6):1383-402.
    View in: PubMed
    Score: 0.048
  8. Impact of safety monitoring on error probabilities of binary efficacy outcome analyses in large phase III group sequential trials. Pharm Stat. 2012 Jul-Aug; 11(4):310-7.
    View in: PubMed
    Score: 0.046
  9. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care. 2011 Dec; 15(3):559-76.
    View in: PubMed
    Score: 0.044
  10. The Albumin in Acute Stroke Part 1 Trial: an exploratory efficacy analysis. Stroke. 2011 Jun; 42(6):1621-5.
    View in: PubMed
    Score: 0.042
  11. Quantifying the cost in power of ignoring continuous covariate imbalances in clinical trial randomization. Contemp Clin Trials. 2011 Mar; 32(2):250-9.
    View in: PubMed
    Score: 0.041
  12. Comments regarding the recent OAST article. Stroke. 2008 Jan; 39(1):e14; author reply e15.
    View in: PubMed
    Score: 0.033
  13. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: neurologic outcome and efficacy analysis. Stroke. 2006 Aug; 37(8):2107-14.
    View in: PubMed
    Score: 0.030
  14. Applying a phase II futility study design to therapeutic stroke trials. Stroke. 2005 Nov; 36(11):2410-4.
    View in: PubMed
    Score: 0.029
  15. A randomized, placebo-controlled trial of buspirone for the treatment of anxiety in opioid-dependent individuals. Am J Addict. 2004 Jan-Feb; 13(1):53-63.
    View in: PubMed
    Score: 0.025
  16. J-shape relation of blood pressure reduction and outcome in acute intracerebral hemorrhage: A pooled analysis of INTERACT2 and ATACH-II individual participant data. Int J Stroke. 2022 12; 17(10):1129-1136.
    View in: PubMed
    Score: 0.022
  17. Intensive blood pressure lowering with nicardipine and outcomes after intracerebral hemorrhage: An individual participant data systematic review. Int J Stroke. 2022 06; 17(5):494-505.
    View in: PubMed
    Score: 0.022
  18. Regional Differences in the Response to Acute Blood Pressure Lowering After Cerebral Hemorrhage. Neurology. 2021 02 02; 96(5):e740-e751.
    View in: PubMed
    Score: 0.021
  19. Sex Differences in Blood Pressure-Lowering Therapy and Outcomes Following Intracerebral Hemorrhage: Results From ATACH-2. Stroke. 2020 08; 51(8):2282-2286.
    View in: PubMed
    Score: 0.020
  20. Late Neurological Deterioration after Acute Intracerebral Hemorrhage: A post hoc Analysis of the ATACH-2 Trial. Cerebrovasc Dis. 2020; 49(1):26-31.
    View in: PubMed
    Score: 0.019
  21. Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis. JAMA Netw Open. 2019 09 04; 2(9):e1910769.
    View in: PubMed
    Score: 0.019
  22. Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data. Lancet Neurol. 2019 09; 18(9):857-864.
    View in: PubMed
    Score: 0.019
  23. Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III. J Neurotrauma. 2019 10 15; 36(20):2863-2871.
    View in: PubMed
    Score: 0.019
  24. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial. Lancet Neurol. 2019 05; 18(5):428-438.
    View in: PubMed
    Score: 0.018
  25. Clinical Outcomes Depending on Acute Blood Pressure After Cerebral Hemorrhage. Ann Neurol. 2019 01; 85(1):105-113.
    View in: PubMed
    Score: 0.018
  26. The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods. Int J Stroke. 2019 02; 14(2):207-214.
    View in: PubMed
    Score: 0.018
  27. Blood Pressure-Attained Analysis of ATACH 2 Trial. Stroke. 2018 06; 49(6):1412-1418.
    View in: PubMed
    Score: 0.017
  28. Prehospital Intubation is Associated with Favorable Outcomes and Lower Mortality in ProTECT III. Prehosp Emerg Care. 2017 Sep-Oct; 21(5):539-544.
    View in: PubMed
    Score: 0.016
  29. Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III. J Am Heart Assoc. 2017 May 08; 6(5).
    View in: PubMed
    Score: 0.016
  30. A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3). Int J Stroke. 2017 10; 12(8):896-905.
    View in: PubMed
    Score: 0.016
  31. Power of logrank test and Cox regression model in clinical trials with heterogeneous samples. Stat Med. 1997 Mar 15; 16(5):583-97.
    View in: PubMed
    Score: 0.016
  32. Intensive Blood-Pressure Lowering in Cerebral Hemorrhage. N Engl J Med. 2016 12 08; 375(23):e48.
    View in: PubMed
    Score: 0.016
  33. Endovascular Therapy of M2 Occlusion in IMS III: Role of M2 Segment Definition and Location on Clinical and Revascularization Outcomes. AJNR Am J Neuroradiol. 2017 Jan; 38(1):84-89.
    View in: PubMed
    Score: 0.015
  34. ALIAS (Albumin in Acute Ischemic Stroke) Trials: Analysis of the Combined Data From Parts 1 and 2. Stroke. 2016 09; 47(9):2355-9.
    View in: PubMed
    Score: 0.015
  35. Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage. N Engl J Med. 2016 09 15; 375(11):1033-43.
    View in: PubMed
    Score: 0.015
  36. Very Early Administration of Progesterone Does Not Improve Neuropsychological Outcomes in Subjects with Moderate to Severe Traumatic Brain Injury. J Neurotrauma. 2017 01 01; 34(1):115-120.
    View in: PubMed
    Score: 0.015
  37. Effect of endovascular reperfusion in relation to site of arterial occlusion. Neurology. 2016 Feb 23; 86(8):762-70.
    View in: PubMed
    Score: 0.015
  38. Endovascular Therapy Is Effective and Safe for Patients With Severe Ischemic Stroke: Pooled Analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Netherlands Data. Stroke. 2015 Dec; 46(12):3416-22.
    View in: PubMed
    Score: 0.014
  39. Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis. Stroke. 2015 Feb; 46(2):461-4.
    View in: PubMed
    Score: 0.014
  40. Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial. Radiology. 2014 Oct; 273(1):202-10.
    View in: PubMed
    Score: 0.013
  41. Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. Lancet Neurol. 2014 Jun; 13(6):567-74.
    View in: PubMed
    Score: 0.013
  42. Challenges of decision making regarding futility in a randomized trial: the Interventional Management of Stroke III experience. Stroke. 2014 May; 45(5):1408-14.
    View in: PubMed
    Score: 0.013
  43. Collaterals at angiography and outcomes in the Interventional Management of Stroke (IMS) III trial. Stroke. 2014 Mar; 45(3):759-64.
    View in: PubMed
    Score: 0.013
  44. Alberta Stroke Program early computed tomography score to select patients for endovascular treatment: Interventional Management of Stroke (IMS)-III Trial. Stroke. 2014 Feb; 45(2):444-9.
    View in: PubMed
    Score: 0.013
  45. High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial. Lancet Neurol. 2013 Nov; 12(11):1049-58.
    View in: PubMed
    Score: 0.013
  46. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013 Mar 07; 368(10):893-903.
    View in: PubMed
    Score: 0.012
  47. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012 Feb 16; 366(7):591-600.
    View in: PubMed
    Score: 0.011
  48. Flexible analytical methods for adding a treatment arm mid-study to an ongoing clinical trial. J Biopharm Stat. 2012; 22(4):758-72.
    View in: PubMed
    Score: 0.011
  49. Strokes with minor symptoms: an exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials. Stroke. 2010 Nov; 41(11):2581-6.
    View in: PubMed
    Score: 0.010
  50. Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study. Arch Neurol. 2010 May; 67(5):570-6.
    View in: PubMed
    Score: 0.010
  51. Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis. Stroke. 2010 Apr; 41(4):732-8.
    View in: PubMed
    Score: 0.010
  52. The impact of loss to follow-up on hypothesis tests of the treatment effect for several statistical methods in substance abuse clinical trials. J Subst Abuse Treat. 2009 Jul; 37(1):54-63.
    View in: PubMed
    Score: 0.009
  53. Revascularization results in the Interventional Management of Stroke II trial. AJNR Am J Neuroradiol. 2008 Mar; 29(3):582-7.
    View in: PubMed
    Score: 0.008
  54. The ALIAS (ALbumin In Acute Stroke) Phase III randomized multicentre clinical trial: design and progress report. Biochem Soc Trans. 2006 Dec; 34(Pt 6):1323-6.
    View in: PubMed
    Score: 0.008
  55. Using the baseline CT scan to select acute stroke patients for IV-IA therapy. AJNR Am J Neuroradiol. 2006 Sep; 27(8):1612-6.
    View in: PubMed
    Score: 0.008
  56. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--I: Physiological responses and safety results. Stroke. 2006 Aug; 37(8):2100-6.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.